Back to 
Morgan Stanley
Morgan Stanley
PPCB
3 quarters
Position history for Morgan Stanley's holdings in Propanc Biopharma, Inc.
No. Morgan Stanley exited its PPCB (Propanc Biopharma) position in Q1 2026. Its Q4 2025 13F listed 1 shares worth $1. Morgan Stanley first reported PPCB in Q3 2025 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$2
Total Shares Change
-1
Quarter-by-Quarter History
Other major holders of PPCB: Marex Group Ltd, Virtu Financial LLC, UBS Group AG, Jane Street Group, LLC